Results of the September 2014 Impact Grants competition

We are pleased to announce the results of the most recent Impact Grants competition. This program has been designed to accelerate and focus the knowledge gained from scientific findings, in the short or long term, into outcomes that will significantly advance understanding of cancer and improve scientific knowledge, which will result in optimized patient care, improved cancer treatment or reduced cancer burden. Below is a listing of newly awarded Canadian Cancer Society (CCS) Impact Grants.

12 Canadian Cancer Society Impact Grants have been approved – 33% of all full proposals received. 90 Letters of Intent were submitted to the competition, and following a scientific review 38 of these were invited to submit full applications, and 36 were received. This flagship program represents the largest project funding to individual investigators awarded by the Canadian Cancer Society. Grants are valued at up to $1.25M over a 5-year term. These 12 new grants represent a significant investment of almost $15 million.

The Canadian Cancer Society and Brain Canada partnered to support additional Impact Grants focused on brain cancer research in this competition. This partnership leverages donations made to the Canadian Cancer Society with matching funds from Brain Canada through the Canada Brain Research Fund, a public-private partnership established by the Government of Canada, enabling more brain cancer research to be funded. In addition, Princess Margaret Cancer Foundation is also partnering with the Canadian Cancer Society to fund an additional Impact Grant.

Summaries of awarded grants

Please note:
  • Amounts listed below represent the total dollars awarded by grant year and may include funds for salaries, supplies, and/or equipment.
  • The start date for these grants is February 1, 2015.
  • Only the Principal Investigator is named in this listing. Co-Principal Investigators, Co-Applicants and/or Additional Authors may also be associated with these grants.
Note Carefully:

Although every effort has been made to ensure the accuracy of the listing below, this list does not constitute an "official" notification.

Successful applicants will be informed, in writing, with an official Notification of Award giving the details pertaining to their grant. 

Applicant
Institution
Title
Award
Bhatia, Mick
McMaster University
Targeting the bone marrow niche to treat human acute myeloid leukemia
2015/2016 :  $250,000
2016/2017 :  $250,000
2017/2018 :  $250,000
2018/2019 :  $250,000
2019/2020 :  $250,000
Cohen, Sandra
Hopital Maisonneuve-Rosemont (affil. U de Montreal)
Expansion of human cord blood hematopoietic stem cells with UM171 in a fed-batch culture system
2015/2016 :  $250,000
2016/2017 :  $250,000
2017/2018 :  $250,000
2018/2019 :  $250,000
2019/2020 :  $250,000
Dedhar, Shoukat
BC Cancer Agency (Vancouver)
New therapeutic strategy targeting tumour hypoxia and carbonic anhydrase IX for the treatment of pancreatic cancer
2015/2016 :  $249,809
2016/2017 :  $249,495
2017/2018 :  $249,590
2018/2019 :  $249,824
2019/2020 :  $249,949
Dick, John
Ontario Cancer Institute/PMCC - UHN
Cellular and molecular mechanisms underlying AML initiation and evolution
2015/2016 :  $250,000
2016/2017 :  $250,000
2017/2018 :  $250,000
2018/2019 :  $250,000
2019/2020 :  $250,000
Ikura, Mitsuhiko
Ontario Cancer Institute/PMCC - UHN
Identification of novel therapeutic strategies for RAS mutations in cancer
*Co-funded by the Princess Margaret Cancer Foundation
2015/2016 :  $250,000
2016/2017 :  $250,000
2017/2018 :  $250,000
2018/2019 :  $250,000
2019/2020 :  $250,000
Liu, Geoffrey
Ontario Cancer Institute/PMCC - UHN
REAL-PDX: Resistance modeling in EGFR and ALK lung cancer patient-derived xenografts for personalized post-progression therapy
2015/2016 :  $250,000
2016/2017 :  $250,000
2017/2018 :  $250,000
2018/2019 :  $250,000
2019/2020 :  $249,999
Martin, Alberto
University of Toronto
The gut microbiota and the etiology of colon cancer
2015/2016 :  $245,897
2016/2017 :  $245,897
2017/2018 :  $245,897
2018/2019 :  $245,897
2019/2020 :  $245,897
Selby, Peter
Centre for Addiction and Mental Health
Personalized dosing of nicotine replacement for smoking cessation: an effectiveness randomized placebo-controlled trial
2015/2016 :  $250,000
2016/2017 :  $250,000
2017/2018 :  $250,000
2018/2019 :  $250,000
2019/2020 :  $239,026
Sorensen, Poul
University of British Columbia
Deciphering eEF2K biological functions for therapeutic targeting of neural tumours
*Co-funded by Brain Canada
2015/2016 :  $250,000
2016/2017 :  $250,000
2017/2018 :  $250,000
2018/2019 :  $250,000
2019/2020 :  $250,000
Stojdl, David
Children's Hospital of Eastern Ontario
Oncolytic rhabdovirus immunotherapy for brain cancer
*Co-funded by Brain Canada
2015/2016 :  $247,700
2016/2017 :  $247,700
2017/2018 :  $247,700
2018/2019 :  $247,700
2019/2020 :  $247,700
Tabori, Uri
The Hospital for Sick Children
Targeting the telomere maintenance pathway for cancer diagnostics and therapeutics
*Co-funded by Brain Canada
2015/2016 :  $249,953
2016/2017 :  $249,953
2017/2018 :  $249,953
2018/2019 :  $249,953
2019/2020 :  $249,953
Taylor, Michael
The Hospital for Sick Children
Molecular heterogeneity drives the clinical behaviour of childhood medulloblastoma
*Co-funded by Brain Canada
2015/2016 :  $249,976
2016/2017 :  $249,976
2017/2018 :  $249,976
2018/2019 :  $249,976
2019/2020 :  $249,976

Last modified on: January 30, 2017